PEG-uricase
RxNorm 1011650
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1011650 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PEG-uricase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
PEG-uricase
(Atom ID: 8719254)
INPrescribable
Ingredient (IN):
Pegloticase
(Atom ID: 12252368)
PTPrescribable
Designated preferred name (PT):
Pegloticase
(Atom ID: 3800428)
FNPrescribable
Full form of descriptor (FN):
Pegloticase (substance)
(Atom ID: 3800429)
PTPrescribable
Designated preferred name (PT):
Pegloticase-containing product
(Atom ID: 10808777)
FNPrescribable
Full form of descriptor (FN):
Product containing pegloticase (medicinal product)
(Atom ID: 10308417)
Patient Education
Pegloticase Injection
Pegloticase injection is used to treat ongoing gout (sudden, severe pain, redness, and swelling in one or more joints caused by abnormally high levels of a substance called uric acid in the blood) in adults who cannot take or did not respond to other medications. Pegloticase injection is in a class of medications called PEGylated uric acid specific enzymes. It works by decreasing the amount of uric acid in the body. Pegloticase injection is used to prevent gout attacks but not to treat them once they occur.
[Learn More]
* Please review the disclaimer below.